Insider · CIK 0001658544

Kelly Paul Edward

Reports to the SEC for 1 company · CORAL GABLES,, FL

sec.gov

Transactions

Companies

Filings

CIK

0001658544

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-12-12	RLMDRELMADA THERAPEUTICS, INC. · Stock Appreciation RightsA Award	Director, COO	AAward	+828K sh	—	—	828,000
2025-11-05	RLMDRELMADA THERAPEUTICS, INC.P Purchase	Director, COO	PPurchase	+90K sh	$2.20	+$198K	502,295
2025-06-26	RLMDRELMADA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director, COO	AAward	+400K sh	—	—	400,000
2025-05-16	RLMDRELMADA THERAPEUTICS, INC.P Purchase	Director, COO	PPurchase	+200K sh	$0.43	+$86.1K	412,295
2024-09-09	RLMDRELMADA THERAPEUTICS, INC.P Purchase	Director, COO	PPurchase	+25K sh	$2.59	+$64.8K	212,295
2024-05-24	RLMDRELMADA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director, COO	AAward	+43.7K sh	—	—	109,372
2024-05-24	RLMDRELMADA THERAPEUTICS, INC. · Stock Option (right to buy)J Other	Director, COO	JOther	−43.7K sh	—	—	65,672
2023-12-15	RLMDRELMADA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director, COO	AAward	+65.7K sh	—	—	65,672
2023-05-25	RLMDRELMADA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director, COO	AAward	+93K sh	—	—	150,000
2022-12-16	RLMDRELMADA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director, COO	AAward	+57K sh	—	—	57,042
2022-05-25	RLMDRELMADA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director, COO	AAward	+182K sh	—	—	300,000
2022-04-04	RLMDRELMADA THERAPEUTICS, INC.M Exercise/Conversion	Director, COO	MExercise/Conversion	+10K sh	$3.24	+$32.4K	197,295
2022-04-04	RLMDRELMADA THERAPEUTICS, INC.S Sale	Director, COO	SSale	−10K sh	$30.04	−$300K	187,295
2022-04-04	RLMDRELMADA THERAPEUTICS, INC. · Options to purchase common stockM Exercise/Conversion	Director, COO	MExercise/Conversion	−10K sh	—	—	20,500
2022-01-03	RLMDRELMADA THERAPEUTICS, INC.M Exercise/Conversion	Director, COO	MExercise/Conversion	−20K sh	$3.24	−$64.8K	187,295
2022-01-03	RLMDRELMADA THERAPEUTICS, INC. · Options to purchase common stockM Exercise/Conversion	Director, COO	MExercise/Conversion	−20K sh	—	—	30,500
2021-12-17	RLMDRELMADA THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director, COO	AAward	+118K sh	—	—	117,530
2021-07-08	RLMDRELMADA THERAPEUTICS, INC. · Stock Option (right to buy)G Gift	Director, COO	GGift	−6,400 sh	—	—	41
2021-07-08	RLMDRELMADA THERAPEUTICS, INC. · Stock Option (right to buy)G Gift	Director, COO	GGift	−19.6K sh	—	—	130,400
2021-07-08	RLMDRELMADA THERAPEUTICS, INC. · Stock Option (right to buy)G Gift	Director, COO	GGift	−56K sh	—	—	94,000
2021-07-08	RLMDRELMADA THERAPEUTICS, INC. · Stock Option (right to buy)G Gift	Director, COO	GGift	−18K sh	—	—	132,000
2021-03-09	RLMDRELMADA THERAPEUTICS, INC.M Exercise/Conversion	Director, COO	MExercise/Conversion	+5,000 sh	$3.24	+$16.2K	172,295
2021-03-09	RLMDRELMADA THERAPEUTICS, INC.S Sale	Director, COO	SSale	−3,388 sh	$35.42	−$120K	168,907
2021-03-09	RLMDRELMADA THERAPEUTICS, INC.S Sale	Director, COO	SSale	−1,612 sh	$36.33	−$58.6K	167,295
2021-03-09	RLMDRELMADA THERAPEUTICS, INC. · Options to purchase common stockM Exercise/Conversion	Director, COO	MExercise/Conversion	−5,000 sh	—	—	50,500
2021-02-24	RLMDRELMADA THERAPEUTICS, INC.M Exercise/Conversion	Director, COO	MExercise/Conversion	+5,000 sh	$3.24	+$16.2K	172,295
2021-02-24	RLMDRELMADA THERAPEUTICS, INC.S Sale	Director, COO	SSale	−2,429 sh	$33.67	−$81.8K	169,866
2021-02-24	RLMDRELMADA THERAPEUTICS, INC.S Sale	Director, COO	SSale	−2,463 sh	$34.64	−$85.3K	167,403
2021-02-24	RLMDRELMADA THERAPEUTICS, INC.S Sale	Director, COO	SSale	−108 sh	$35.58	−$3,842.921	167,295
2021-02-16	RLMDRELMADA THERAPEUTICS, INC.M Exercise/Conversion	Director, COO	MExercise/Conversion	+5,000 sh	$6.00	+$30K	167,295
2021-02-16	RLMDRELMADA THERAPEUTICS, INC. · WarrantsM Exercise/Conversion	Director, COO	MExercise/Conversion	−5,000 sh	$6.00	−$30K	20,000
2021-02-09	RLMDRELMADA THERAPEUTICS, INC.S Sale	Director, COO	SSale	−2,069 sh	$35.28	−$73K	162,295
2021-02-08	RLMDRELMADA THERAPEUTICS, INC.M Exercise/Conversion	Director, COO	MExercise/Conversion	+3,569 sh	$3.24	+$11.6K	165,864
2021-02-08	RLMDRELMADA THERAPEUTICS, INC.S Sale	Director, COO	SSale	−1,500 sh	$35.04	−$52.6K	164,364
2021-02-08	RLMDRELMADA THERAPEUTICS, INC. · Options to purchase common stockM Exercise/Conversion	Director, COO	MExercise/Conversion	−3,569 sh	—	—	60,500
2021-02-08	RLMDRELMADA THERAPEUTICS, INC. · Options to purchase common stockM Exercise/Conversion	Director, COO	MExercise/Conversion	−5,000 sh	—	—	55,500
2021-02-02	RLMDRELMADA THERAPEUTICS, INC.S Sale	Director, COO	SSale	−2,315 sh	$35.04	−$81.1K	162,295
2021-02-01	RLMDRELMADA THERAPEUTICS, INC.M Exercise/Conversion	Director, COO	MExercise/Conversion	+15K sh	$3.24	+$48.6K	162,295
2021-02-01	RLMDRELMADA THERAPEUTICS, INC.M Exercise/Conversion	Director, COO	MExercise/Conversion	+2,346 sh	$3.24	+$7,601.04	164,641
2021-02-01	RLMDRELMADA THERAPEUTICS, INC.S Sale	Director, COO	SSale	−31 sh	$35.00	−$1,085	164,610
2021-02-01	RLMDRELMADA THERAPEUTICS, INC. · Options to purchase common stockM Exercise/Conversion	Director, COO	MExercise/Conversion	−15K sh	—	—	66,415
2021-02-01	RLMDRELMADA THERAPEUTICS, INC. · Options to purchase common stockM Exercise/Conversion	Director, COO	MExercise/Conversion	−2,346 sh	—	—	64,069
2021-01-27	RLMDRELMADA THERAPEUTICS, INC.M Exercise/Conversion	Director, COO	MExercise/Conversion	+5,000 sh	$3.24	+$16.2K	152,295
2021-01-27	RLMDRELMADA THERAPEUTICS, INC.S Sale	Director, COO	SSale	−1,844 sh	$31.69	−$58.4K	150,451
2021-01-27	RLMDRELMADA THERAPEUTICS, INC.S Sale	Director, COO	SSale	−2,988 sh	$32.89	−$98.3K	147,463
2021-01-27	RLMDRELMADA THERAPEUTICS, INC.S Sale	Director, COO	SSale	−168 sh	$33.40	−$5,611.2	147,295
2021-01-27	RLMDRELMADA THERAPEUTICS, INC. · Options to purchase common stockM Exercise/Conversion	Director, COO	MExercise/Conversion	−5,000 sh	—	—	81,415
2021-01-26	RLMDRELMADA THERAPEUTICS, INC.S Sale	Director, COO	SSale	−685 sh	$35.16	−$24.1K	147,295
2021-01-25	RLMDRELMADA THERAPEUTICS, INC.S Sale	Director, COO	SSale	−1,300 sh	$35.27	−$45.9K	147,980
2021-01-22	RLMDRELMADA THERAPEUTICS, INC.S Sale	Director, COO	SSale	−1,800 sh	$35.43	−$63.8K	149,580

Recent filings

Accepted (ET)
Dec 164
Kelly Paul Edward0001213900-25-121968
SEC(opens sec.gov)
Nov 64
Kelly Paul Edward0001213900-25-106835
SEC(opens sec.gov)
Jun 304
Kelly Paul Edward0001213900-25-059864
SEC(opens sec.gov)
May 204
Kelly Paul Edward0001213900-25-046088
SEC(opens sec.gov)
Sep 114
Kelly Paul Edward0001213900-24-077791
SEC(opens sec.gov)
May 294
Kelly Paul Edward0001213900-24-047637
SEC(opens sec.gov)
Dec 194
Kelly Paul Edward0001213900-23-097029
SEC(opens sec.gov)
May 304
Kelly Paul Edward0001213900-23-044087
SEC(opens sec.gov)
Feb 25
Kelly Paul Edward0001213900-23-007438
SEC(opens sec.gov)
Dec 204
Kelly Paul Edward0001213900-22-081477
SEC(opens sec.gov)
May 264
Kelly Paul Edward0001213900-22-029838
SEC(opens sec.gov)
Apr 54
Kelly Paul Edward0001213900-22-018223
SEC(opens sec.gov)
Jan 54
Kelly Paul Edward0001213900-22-000761
SEC(opens sec.gov)

Companies

RELMADA THERAPEUTICS, INC.Director, COORLMD

Address

C/O RELMADA THERAPEUTICS, INC. 2222 PONCE DE LEON BLVD, 3RD FLOOR

CORAL GABLES,, FL, 33134